Always good to be invested with you & been very glad to see you here @ma420
You are too kind & polite wrt my knowledge drugs chemistry, & drug trials research ability —to at all best analyse or write up performance comparisons between DXM-200 & Travere and corollaries end- points validation, timelines etal.
I do think that FSGC is the more compelling and greater benefit to be gained, in the renal treatment field for patients. My knowledge pharmacology & drugs commercialisation is low
I appreciate your work and research that you post very much. Thankyou for all that you share.
DXB Price at posting:
43.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)